Jones Day welcomes Yi Han Dulkeith to New York Office as of counsel in Intellectual Property Practice
Yi Han Dulkeith, Ph.D., has joined the Firm as of counsel in the Intellectual Property Practice. She is based in the New York Office.
Dr. Dulkeith focuses on strategic patent portfolio development and counseling to world-class research institutions and universities as well as leading biotechnology and biopharmaceutical companies. Given her education and training, Dr. Dulkeith advises clients on their cutting-edge technologies including immunotherapy, gene editing, and cell therapies, including stem cell technology, engineered cells, and diagnostics.
"Yi brings her impressive combination of legal and biotechnology skills and training to advise emerging and world-leading biotech and biopharmaceutical companies," said Anthony M. Insogna, Practice Leader of the Firm's Intellectual Property Practice. "In particular, her experience with strategic portfolio management and prosecution, due diligence, and post-grant proceedings will be a tremendous asset to our clients. I am pleased to welcome Yi to Jones Day."
At Jones Day, Dr. Dulkeith joins one of the few global law firms with a full-service intellectual property practice that assists life sciences companies with patent strategy, litigation, and transactions involving their most important assets. The Firm's worldwide team of IP lawyers includes more than 200 professionals who leverage courtroom skills and advanced degrees in chemistry, biology, and immunology to help clients win key disputes across patent offices and courtrooms, as well as to build IP portfolios and add value to their IP assets.
"With extensive experience representing nonprofit and health-care organizations and research institutes, as well as start-up biotech companies and multinational biopharmaceutical companies, Yi's distinctive blend of deep technical knowledge and proven legal skills will be a terrific benefit for our clients," said Leon F. DeJulius Jr., Partner-in-Charge of Jones Day's New York Office.
Dr. Dulkeith began her career in the legal profession as a science advisor, handling patent prosecution matters and opinions, as well as directing and devising strategies in re-examination proceedings before the U.S. Patent and Trademark Office.
Dr. Dulkeith earned her law degree from Fordham University School of Law. She obtained both Master of Science and Ph.D. degrees in molecular, cellular, and developmental biology from Yale University. Dr. Dulkeith received her undergraduate degree from Peking University in Beijing, China.